Browse the complete record of transactions filed by Arrow Alexander K., Chief Financial Officer. Insider active across 1 companies, notably Protagenic Therapeutics, Inc.\new. In total, 3 filings have been published. Total volume traded: €19k. The latest transaction was disclosed on 17 May 2022 — Acquisition. Regulator: SEC (Form 4). The full history is free.
3 of 3 declarations
Arrow Alexander K. is the Chief Financial Officer at Protagenic Therapeutics, Inc. In this role, he oversees the company's financial operations and is involved in strategic decision-making. His expertise in finance allows him to effectively manage financial resources and optimize the company's performance. He collaborates with other executives to ensure growth and profitability.